Atlas Invest | $25,000,000 | (Jan 22, 2026)
AiStrike | $7,000,000 | (Jan 22, 2026)
Zarminali Pediatrics | $110,000,000 | (Jan 22, 2026)
BIOWEG
Germany
- Quakenbrück, Niedersachsen
- 17/09/2025
- Series A
- $18,970,160
BIOWEG, founded in 2019 in Germany, is a purpose-driven organization powered by conscious ChemDesign.
We match Bio-innovation to business problems. We explore and combine biotechnology, material science, and molecular simulation learning to create advanced sustainable bio-based high-performance ingredients.
Our ingredients are 100% animal free, globally scalable, and sustainably produced without harsh chemicals.
We work with results-oriented, forward-thinking companies, and consumer brands with global scale in the cosmetics, personal care, nutraceuticals, agricultural coatings, and food/beverage sectors who desire highly differentiated and sustainable science-based ingredient technologies.
- Industry Biotechnology Research
- Website https://bioweg.com/
- LinkedIn https://www.linkedin.com/company/bioweg/
Related People
Prateek M.Founder
Germany -
Düsseldorf, North Rhine-Westphalia
Entrepreneur and CEO with a passion for impact-driven businesses. BIOWEG offers fossil fuel free Ingredients for FMCG and Agricuture industry.
At BIOWEG, we combat microplastic pollution through zero-waste circular processes, biotech, fermentation, formulations and green chemistry.
Previously, I had worked in strategy consulting, policy making, lobbying and co-founded and worked with other startups. My academic background includes a Ph.D. from the Max Planck Society in Germany, where I had the privilege to work under the direct supervision of Nobel laureate Prof. Christiane Nüsslein-Volhard.
One to One Health | $12,000,000 | (Jan 22, 2026)
AnswersNow | $40,000,000 | (Jan 22, 2026)
Claim Health | $4,400,000 | (Jan 22, 2026)
Upscale AI(US) | $200,000,000 | (Jan 22, 2026)
Nasdaq Private Market | $37,600,000 | (Jan 22, 2026)
PraxisPro | $6,000,000 | (Jan 22, 2026)
furl | $10,000,000 | (Jan 22, 2026)
humans& | $480,000,000 | (Jan 22, 2026)
Think Bioscience | $55,000,000 | (Jan 21, 2026)